KBL Merger Corp. IV - CW23ETHZWPreferred / convertible
13F holders, Q3 2024 (September 30)3holders −1
0new positions
1sold out
$0.01avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding KBL Merger Corp. IV - CW23 (ETHZW) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Cowen and Company, LLC ($505), Wolverine Asset Management LLC ($73) and UBS Group AG ($1).
- Company
- KBL Merger Corp. IV - CW23
- Filed as
- 180 LIFE SCIENCES CORP (Q3 2024)
- CUSIP
- 68236V112
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $384 |
All 13F filers, Q2 2024 → Q3 2024: 37,503 shares sold, net −37,503 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Cowen and Company, LLC | — | Reduce -0.3% | 71,715 | $505 |
| Wolverine Asset Management LLC | — | No change | 10,348 | $73 |
| UBS Group AG | — | Reduce -70.2% | 165 | $1 |
"% of holder's portfolio" is ETHZW's weight in each manager's 13F, not the share of KBL Merger Corp. IV - CW23 the manager owns.